BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25092905)

  • 1. The GalNAc-type O-Glycoproteome of CHO cells characterized by the SimpleCell strategy.
    Yang Z; Halim A; Narimatsu Y; Jitendra Joshi H; Steentoft C; Schjoldager KT; Alder Schulz M; Sealover NR; Kayser KJ; Paul Bennett E; Levery SB; Vakhrushev SY; Clausen H
    Mol Cell Proteomics; 2014 Dec; 13(12):3224-35. PubMed ID: 25092905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced mass spectrometric mapping of the human GalNAc-type O-glycoproteome with SimpleCells.
    Vakhrushev SY; Steentoft C; Vester-Christensen MB; Bennett EP; Clausen H; Levery SB
    Mol Cell Proteomics; 2013 Apr; 12(4):932-44. PubMed ID: 23399548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology.
    Steentoft C; Vakhrushev SY; Joshi HJ; Kong Y; Vester-Christensen MB; Schjoldager KT; Lavrsen K; Dabelsteen S; Pedersen NB; Marcos-Silva L; Gupta R; Bennett EP; Mandel U; Brunak S; Wandall HH; Levery SB; Clausen H
    EMBO J; 2013 May; 32(10):1478-88. PubMed ID: 23584533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific O-glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates human δ-opioid receptor turnover at the plasma membrane.
    Lackman JJ; Goth CK; Halim A; Vakhrushev SY; Clausen H; Petäjä-Repo UE
    Cell Signal; 2018 Jan; 42():184-193. PubMed ID: 29097258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells.
    Schjoldager KT; Vakhrushev SY; Kong Y; Steentoft C; Nudelman AS; Pedersen NB; Wandall HH; Mandel U; Bennett EP; Levery SB; Clausen H
    Proc Natl Acad Sci U S A; 2012 Jun; 109(25):9893-8. PubMed ID: 22566642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing polypeptide GalNAc-transferase isoform substrate specificities by in vitro analysis.
    Kong Y; Joshi HJ; Schjoldager KT; Madsen TD; Gerken TA; Vester-Christensen MB; Wandall HH; Bennett EP; Levery SB; Vakhrushev SY; Clausen H
    Glycobiology; 2015 Jan; 25(1):55-65. PubMed ID: 25155433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering mammalian mucin-type O-glycosylation in plants.
    Yang Z; Drew DP; Jørgensen B; Mandel U; Bach SS; Ulvskov P; Levery SB; Bennett EP; Clausen H; Petersen BL
    J Biol Chem; 2012 Apr; 287(15):11911-23. PubMed ID: 22334671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study on enhanced O-glycosylation strategy for improved production of recombinant human chorionic gonadotropin in Chinese hamster ovary cells.
    Deng Z; Yi X; Chu J; Zhuang Y
    J Biotechnol; 2019 Dec; 306():159-168. PubMed ID: 31604106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the contribution of individual polypeptide GalNAc-transferase isoforms to the
    Hintze J; Ye Z; Narimatsu Y; Madsen TD; Joshi HJ; Goth CK; Linstedt A; Bachert C; Mandel U; Bennett EP; Vakhrushev SY; Schjoldager KT
    J Biol Chem; 2018 Dec; 293(49):19064-19077. PubMed ID: 30327431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Glycoproteomic Analysis of Chinese Hamster Ovary Cells.
    Yang G; Hu Y; Sun S; Ouyang C; Yang W; Wang Q; Betenbaugh M; Zhang H
    Anal Chem; 2018 Dec; 90(24):14294-14302. PubMed ID: 30457839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deconstruction of O-glycosylation--GalNAc-T isoforms direct distinct subsets of the O-glycoproteome.
    Schjoldager KT; Joshi HJ; Kong Y; Goth CK; King SL; Wandall HH; Bennett EP; Vakhrushev SY; Clausen H
    EMBO Rep; 2015 Dec; 16(12):1713-22. PubMed ID: 26566661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting host O-linked glycan biosynthesis affects Ebola virus replication efficiency and reveals differential GalNAc-T acceptor site preferences on the Ebola virus glycoprotein.
    Bagdonaite I; Abdurahman S; Mirandola M; Pasqual D; Frank M; Narimatsu Y; Joshi HJ; Vakhrushev SY; Salata C; Mirazimi A; Wandall HH
    J Virol; 2024 Jun; 98(6):e0052424. PubMed ID: 38757972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential inhibition of mucin-type O-glycosylation (MTOG) induced by peracetyl N-thioglycolyl-d-galactosamine (Ac
    Dwivedi V; Saini P; Tasneem A; Agarwal K; Sampathkumar SG
    Biochem Biophys Res Commun; 2018 Nov; 506(1):60-65. PubMed ID: 30336974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific protein O-glycosylation modulates proprotein processing - deciphering specific functions of the large polypeptide GalNAc-transferase gene family.
    Schjoldager KT; Clausen H
    Biochim Biophys Acta; 2012 Dec; 1820(12):2079-94. PubMed ID: 23022508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A theoretical estimate for nucleotide sugar demand towards Chinese Hamster Ovary cellular glycosylation.
    Del Val IJ; Polizzi KM; Kontoravdi C
    Sci Rep; 2016 Jun; 6():28547. PubMed ID: 27345611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoengineering of human cell lines using zinc finger nuclease gene targeting: SimpleCells with homogeneous GalNAc O-glycosylation allow isolation of the O-glycoproteome by one-step lectin affinity chromatography.
    Steentoft C; Bennett EP; Clausen H
    Methods Mol Biol; 2013; 1022():387-402. PubMed ID: 23765677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation.
    Wandall HH; Irazoqui F; Tarp MA; Bennett EP; Mandel U; Takeuchi H; Kato K; Irimura T; Suryanarayanan G; Hollingsworth MA; Clausen H
    Glycobiology; 2007 Apr; 17(4):374-87. PubMed ID: 17215257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative mapping of the in vivo O-GalNAc glycoproteome in mouse tissues identifies GalNAc-T2 O-glycosites in metabolic disorder.
    Yang W; Tian E; Chernish A; McCluggage P; Dalal K; Lara A; Ten Hagen KG; Tabak LA
    Proc Natl Acad Sci U S A; 2023 Oct; 120(43):e2303703120. PubMed ID: 37862385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic glycoengineering through the mammalian GalNAc salvage pathway.
    Pouilly S; Piller V; Piller F
    FEBS J; 2012 Feb; 279(4):586-98. PubMed ID: 22151230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-specific transfer of N-acetylgalactosamine to O-linked glycans by the glycosyltransferases β1,4-N-acetylgalactosaminyl transferase 3 (β4GalNAc-T3) and β4GalNAc-T4.
    Fiete D; Beranek M; Baenziger JU
    J Biol Chem; 2012 Aug; 287(34):29204-12. PubMed ID: 22722940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.